0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
PD-L1 and PIK3CA Testing Product - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-23W10342
Home | Market Reports | Health| Pharmacy
Global and United States PD L1 and PIK3CA Testing Product Market Report Forecast 2022 2028
BUY CHAPTERS

PD-L1 and PIK3CA Testing Product - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-23W10342
Report
November 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

PD-L1 and PIK3CA Testing Product - Market Size

Testing Product was estimated to be worth US$ 521.8 million in 2023 and is forecast to a readjusted size of US$ 1099.4 million by 2030 with a CAGR of 11.0% during the forecast period 2024-2030

PD-L1 and PIK3CA Testing Product - Market

PD-L1 and PIK3CA Testing Product - Market

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations.
PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.
The global market for PD-L1 and PIK3CA
The classification of PD-L1 and PIK3CA Testing Product includes PD-L1 Testing and PIK3CA Testing. PD-L1 accounted for a share of 80% in the global PD-L1 and PIK3CA Testing Product market.
PD-L1 and PIK3CA Testing Product is widely used in Hospital, Diagnostic Center and Other. In PD-L1 and PIK3CA Testing Product market, the Diagnostic Center holds an important share in terms of Application.
North America is the largest consumption place, with a market share nearly 57% . Following North America, Europe is the second largest consumption place with the market share of 28%.
Market competition is intense. Agilent Technologies, Roche, QIAGEN, Amoy Diagnostics, ACCB Biotech, etc. The top five vendors held 84% of the market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PD-L1 and PIK3CA Testing Product, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of PD-L1 and PIK3CA Testing Product by region & country, by Type, and by Application.
The PD-L1 and PIK3CA Testing Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-L1 and PIK3CA Testing Product.
Market Segmentation

Scope of PD-L1 and PIK3CA Testing Product - Market Report

Report Metric Details
Report Name PD-L1 and PIK3CA Testing Product - Market
Forecasted market size in 2030 US$ 1099.4 million
CAGR 11.0%
Forecasted years 2024 - 2030
Segment by Type:
  • PD-L1
  • PIK3CA
Segment by Application
  • Hospital
  • Diagnostic Center
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agilent Technologies, Roche, QIAGEN, EntroGen, Foundation Medicine, Amoy Diagnostics, ACCB Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of PD-L1 and PIK3CA Testing Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of PD-L1 and PIK3CA Testing Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of PD-L1 and PIK3CA Testing Product in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the PD-L1 and PIK3CA Testing Product - Market size in 2030?

Ans: The PD-L1 and PIK3CA Testing Product - Market size in 2030 will be US$ 1099.4 million.

What is the PD-L1 and PIK3CA Testing Product - Market share by region?

Ans: North America is the largest consumption place, with a market share nearly 57% .

Who are the main players in the PD-L1 and PIK3CA Testing Product - Market report?

Ans: The main players in the PD-L1 and PIK3CA Testing Product - Market are Agilent Technologies, Roche, QIAGEN, EntroGen, Foundation Medicine, Amoy Diagnostics, ACCB Biotech

What are the Application segmentation covered in the PD-L1 and PIK3CA Testing Product - Market report?

Ans: The Applications covered in the PD-L1 and PIK3CA Testing Product - Market report are Hospital, Diagnostic Center, Others

What are the Type segmentation covered in the PD-L1 and PIK3CA Testing Product - Market report?

Ans: The Types covered in the PD-L1 and PIK3CA Testing Product - Market report are PD-L1, PIK3CA

1 Market Overview
1.1 PD-L1 and PIK3CA Testing Product Product Introduction
1.2 Global PD-L1 and PIK3CA Testing Product Market Size Forecast
1.2.1 Global PD-L1 and PIK3CA Testing Product Sales Value (2019-2030)
1.2.2 Global PD-L1 and PIK3CA Testing Product Sales Volume (2019-2030)
1.2.3 Global PD-L1 and PIK3CA Testing Product Sales Price (2019-2030)
1.3 PD-L1 and PIK3CA Testing Product Market Trends & Drivers
1.3.1 PD-L1 and PIK3CA Testing Product Industry Trends
1.3.2 PD-L1 and PIK3CA Testing Product Market Drivers & Opportunity
1.3.3 PD-L1 and PIK3CA Testing Product Market Challenges
1.3.4 PD-L1 and PIK3CA Testing Product Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global PD-L1 and PIK3CA Testing Product Players Revenue Ranking (2023)
2.2 Global PD-L1 and PIK3CA Testing Product Revenue by Company (2019-2024)
2.3 Global PD-L1 and PIK3CA Testing Product Players Sales Volume Ranking (2023)
2.4 Global PD-L1 and PIK3CA Testing Product Sales Volume by Company Players (2019-2024)
2.5 Global PD-L1 and PIK3CA Testing Product Average Price by Company (2019-2024)
2.6 Key Manufacturers PD-L1 and PIK3CA Testing Product Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers PD-L1 and PIK3CA Testing Product Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of PD-L1 and PIK3CA Testing Product
2.9 PD-L1 and PIK3CA Testing Product Market Competitive Analysis
2.9.1 PD-L1 and PIK3CA Testing Product Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by PD-L1 and PIK3CA Testing Product Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 and PIK3CA Testing Product as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PD-L1
3.1.2 PIK3CA
3.2 Global PD-L1 and PIK3CA Testing Product Sales Value by Type
3.2.1 Global PD-L1 and PIK3CA Testing Product Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global PD-L1 and PIK3CA Testing Product Sales Value, by Type (2019-2030)
3.2.3 Global PD-L1 and PIK3CA Testing Product Sales Value, by Type (%) (2019-2030)
3.3 Global PD-L1 and PIK3CA Testing Product Sales Volume by Type
3.3.1 Global PD-L1 and PIK3CA Testing Product Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global PD-L1 and PIK3CA Testing Product Sales Volume, by Type (2019-2030)
3.3.3 Global PD-L1 and PIK3CA Testing Product Sales Volume, by Type (%) (2019-2030)
3.4 Global PD-L1 and PIK3CA Testing Product Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Diagnostic Center
4.1.3 Others
4.2 Global PD-L1 and PIK3CA Testing Product Sales Value by Application
4.2.1 Global PD-L1 and PIK3CA Testing Product Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global PD-L1 and PIK3CA Testing Product Sales Value, by Application (2019-2030)
4.2.3 Global PD-L1 and PIK3CA Testing Product Sales Value, by Application (%) (2019-2030)
4.3 Global PD-L1 and PIK3CA Testing Product Sales Volume by Application
4.3.1 Global PD-L1 and PIK3CA Testing Product Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global PD-L1 and PIK3CA Testing Product Sales Volume, by Application (2019-2030)
4.3.3 Global PD-L1 and PIK3CA Testing Product Sales Volume, by Application (%) (2019-2030)
4.4 Global PD-L1 and PIK3CA Testing Product Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global PD-L1 and PIK3CA Testing Product Sales Value by Region
5.1.1 Global PD-L1 and PIK3CA Testing Product Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global PD-L1 and PIK3CA Testing Product Sales Value by Region (2019-2024)
5.1.3 Global PD-L1 and PIK3CA Testing Product Sales Value by Region (2025-2030)
5.1.4 Global PD-L1 and PIK3CA Testing Product Sales Value by Region (%), (2019-2030)
5.2 Global PD-L1 and PIK3CA Testing Product Sales Volume by Region
5.2.1 Global PD-L1 and PIK3CA Testing Product Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global PD-L1 and PIK3CA Testing Product Sales Volume by Region (2019-2024)
5.2.3 Global PD-L1 and PIK3CA Testing Product Sales Volume by Region (2025-2030)
5.2.4 Global PD-L1 and PIK3CA Testing Product Sales Volume by Region (%), (2019-2030)
5.3 Global PD-L1 and PIK3CA Testing Product Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
5.4.2 North America PD-L1 and PIK3CA Testing Product Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
5.5.2 Europe PD-L1 and PIK3CA Testing Product Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
5.6.2 Asia Pacific PD-L1 and PIK3CA Testing Product Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
5.7.2 South America PD-L1 and PIK3CA Testing Product Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
5.8.2 Middle East & Africa PD-L1 and PIK3CA Testing Product Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions PD-L1 and PIK3CA Testing Product Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions PD-L1 and PIK3CA Testing Product Sales Value
6.2.1 Key Countries/Regions PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
6.2.2 Key Countries/Regions PD-L1 and PIK3CA Testing Product Sales Volume, 2019-2030
6.3 United States
6.3.1 United States PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
6.3.2 United States PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
6.3.3 United States PD-L1 and PIK3CA Testing Product Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
6.4.2 Europe PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe PD-L1 and PIK3CA Testing Product Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
6.5.2 China PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
6.5.3 China PD-L1 and PIK3CA Testing Product Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
6.6.2 Japan PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan PD-L1 and PIK3CA Testing Product Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
6.7.2 South Korea PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea PD-L1 and PIK3CA Testing Product Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
6.8.2 Southeast Asia PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia PD-L1 and PIK3CA Testing Product Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India PD-L1 and PIK3CA Testing Product Sales Value, 2019-2030
6.9.2 India PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
6.9.3 India PD-L1 and PIK3CA Testing Product Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Company Information
7.1.2 Agilent Technologies Introduction and Business Overview
7.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Agilent Technologies PD-L1 and PIK3CA Testing Product Product Offerings
7.1.5 Agilent Technologies Recent Development
7.2 Roche
7.2.1 Roche Company Information
7.2.2 Roche Introduction and Business Overview
7.2.3 Roche PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Roche PD-L1 and PIK3CA Testing Product Product Offerings
7.2.5 Roche Recent Development
7.3 QIAGEN
7.3.1 QIAGEN Company Information
7.3.2 QIAGEN Introduction and Business Overview
7.3.3 QIAGEN PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2019-2024)
7.3.4 QIAGEN PD-L1 and PIK3CA Testing Product Product Offerings
7.3.5 QIAGEN Recent Development
7.4 EntroGen
7.4.1 EntroGen Company Information
7.4.2 EntroGen Introduction and Business Overview
7.4.3 EntroGen PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2019-2024)
7.4.4 EntroGen PD-L1 and PIK3CA Testing Product Product Offerings
7.4.5 EntroGen Recent Development
7.5 Foundation Medicine
7.5.1 Foundation Medicine Company Information
7.5.2 Foundation Medicine Introduction and Business Overview
7.5.3 Foundation Medicine PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Foundation Medicine PD-L1 and PIK3CA Testing Product Product Offerings
7.5.5 Foundation Medicine Recent Development
7.6 Amoy Diagnostics
7.6.1 Amoy Diagnostics Company Information
7.6.2 Amoy Diagnostics Introduction and Business Overview
7.6.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Product Offerings
7.6.5 Amoy Diagnostics Recent Development
7.7 ACCB Biotech
7.7.1 ACCB Biotech Company Information
7.7.2 ACCB Biotech Introduction and Business Overview
7.7.3 ACCB Biotech PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2019-2024)
7.7.4 ACCB Biotech PD-L1 and PIK3CA Testing Product Product Offerings
7.7.5 ACCB Biotech Recent Development
8 Industry Chain Analysis
8.1 PD-L1 and PIK3CA Testing Product Industrial Chain
8.2 PD-L1 and PIK3CA Testing Product Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 PD-L1 and PIK3CA Testing Product Sales Model
8.5.2 Sales Channel
8.5.3 PD-L1 and PIK3CA Testing Product Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. PD-L1 and PIK3CA Testing Product Market Trends
    Table 2. PD-L1 and PIK3CA Testing Product Market Drivers & Opportunity
    Table 3. PD-L1 and PIK3CA Testing Product Market Challenges
    Table 4. PD-L1 and PIK3CA Testing Product Market Restraints
    Table 5. Global PD-L1 and PIK3CA Testing Product Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Company (2019-2024)
    Table 7. Global PD-L1 and PIK3CA Testing Product Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global PD-L1 and PIK3CA Testing Product Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market PD-L1 and PIK3CA Testing Product Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers PD-L1 and PIK3CA Testing Product Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers PD-L1 and PIK3CA Testing Product Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of PD-L1 and PIK3CA Testing Product
    Table 13. Global PD-L1 and PIK3CA Testing Product Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 and PIK3CA Testing Product as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global PD-L1 and PIK3CA Testing Product Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global PD-L1 and PIK3CA Testing Product Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global PD-L1 and PIK3CA Testing Product Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global PD-L1 and PIK3CA Testing Product Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global PD-L1 and PIK3CA Testing Product Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global PD-L1 and PIK3CA Testing Product Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global PD-L1 and PIK3CA Testing Product Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global PD-L1 and PIK3CA Testing Product Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global PD-L1 and PIK3CA Testing Product Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global PD-L1 and PIK3CA Testing Product Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global PD-L1 and PIK3CA Testing Product Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global PD-L1 and PIK3CA Testing Product Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global PD-L1 and PIK3CA Testing Product Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global PD-L1 and PIK3CA Testing Product Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global PD-L1 and PIK3CA Testing Product Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global PD-L1 and PIK3CA Testing Product Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global PD-L1 and PIK3CA Testing Product Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global PD-L1 and PIK3CA Testing Product Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global PD-L1 and PIK3CA Testing Product Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global PD-L1 and PIK3CA Testing Product Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global PD-L1 and PIK3CA Testing Product Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global PD-L1 and PIK3CA Testing Product Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global PD-L1 and PIK3CA Testing Product Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global PD-L1 and PIK3CA Testing Product Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global PD-L1 and PIK3CA Testing Product Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global PD-L1 and PIK3CA Testing Product Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global PD-L1 and PIK3CA Testing Product Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global PD-L1 and PIK3CA Testing Product Sales Value by Region (2019-2024) & (%)
    Table 44. Global PD-L1 and PIK3CA Testing Product Sales Value by Region (2025-2030) & (%)
    Table 45. Global PD-L1 and PIK3CA Testing Product Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global PD-L1 and PIK3CA Testing Product Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global PD-L1 and PIK3CA Testing Product Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global PD-L1 and PIK3CA Testing Product Sales Volume by Region (2019-2024) & (%)
    Table 49. Global PD-L1 and PIK3CA Testing Product Sales Volume by Region (2025-2030) & (%)
    Table 50. Global PD-L1 and PIK3CA Testing Product Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global PD-L1 and PIK3CA Testing Product Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions PD-L1 and PIK3CA Testing Product Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions PD-L1 and PIK3CA Testing Product Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions PD-L1 and PIK3CA Testing Product Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions PD-L1 and PIK3CA Testing Product Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions PD-L1 and PIK3CA Testing Product Sales Volume, (2025-2030) & (K Units)
    Table 57. Agilent Technologies Company Information
    Table 58. Agilent Technologies Introduction and Business Overview
    Table 59. Agilent Technologies PD-L1 and PIK3CA Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Agilent Technologies PD-L1 and PIK3CA Testing Product Product Offerings
    Table 61. Agilent Technologies Recent Development
    Table 62. Roche Company Information
    Table 63. Roche Introduction and Business Overview
    Table 64. Roche PD-L1 and PIK3CA Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Roche PD-L1 and PIK3CA Testing Product Product Offerings
    Table 66. Roche Recent Development
    Table 67. QIAGEN Company Information
    Table 68. QIAGEN Introduction and Business Overview
    Table 69. QIAGEN PD-L1 and PIK3CA Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. QIAGEN PD-L1 and PIK3CA Testing Product Product Offerings
    Table 71. QIAGEN Recent Development
    Table 72. EntroGen Company Information
    Table 73. EntroGen Introduction and Business Overview
    Table 74. EntroGen PD-L1 and PIK3CA Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. EntroGen PD-L1 and PIK3CA Testing Product Product Offerings
    Table 76. EntroGen Recent Development
    Table 77. Foundation Medicine Company Information
    Table 78. Foundation Medicine Introduction and Business Overview
    Table 79. Foundation Medicine PD-L1 and PIK3CA Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Foundation Medicine PD-L1 and PIK3CA Testing Product Product Offerings
    Table 81. Foundation Medicine Recent Development
    Table 82. Amoy Diagnostics Company Information
    Table 83. Amoy Diagnostics Introduction and Business Overview
    Table 84. Amoy Diagnostics PD-L1 and PIK3CA Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Amoy Diagnostics PD-L1 and PIK3CA Testing Product Product Offerings
    Table 86. Amoy Diagnostics Recent Development
    Table 87. ACCB Biotech Company Information
    Table 88. ACCB Biotech Introduction and Business Overview
    Table 89. ACCB Biotech PD-L1 and PIK3CA Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. ACCB Biotech PD-L1 and PIK3CA Testing Product Product Offerings
    Table 91. ACCB Biotech Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. PD-L1 and PIK3CA Testing Product Downstream Customers
    Table 95. PD-L1 and PIK3CA Testing Product Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. PD-L1 and PIK3CA Testing Product Product Picture
    Figure 2. Global PD-L1 and PIK3CA Testing Product Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global PD-L1 and PIK3CA Testing Product Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global PD-L1 and PIK3CA Testing Product Sales Volume (2019-2030) & (K Units)
    Figure 5. Global PD-L1 and PIK3CA Testing Product Sales Price (2019-2030) & (US$/Unit)
    Figure 6. PD-L1 and PIK3CA Testing Product Report Years Considered
    Figure 7. Global PD-L1 and PIK3CA Testing Product Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global PD-L1 and PIK3CA Testing Product Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-L1 and PIK3CA Testing Product Revenue in 2023
    Figure 10. PD-L1 and PIK3CA Testing Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. PD-L1 Picture
    Figure 12. PIK3CA Picture
    Figure 13. Global PD-L1 and PIK3CA Testing Product Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global PD-L1 and PIK3CA Testing Product Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global PD-L1 and PIK3CA Testing Product Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global PD-L1 and PIK3CA Testing Product Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global PD-L1 and PIK3CA Testing Product Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Diagnostic Center
    Figure 20. Product Picture of Others
    Figure 21. Global PD-L1 and PIK3CA Testing Product Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global PD-L1 and PIK3CA Testing Product Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global PD-L1 and PIK3CA Testing Product Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global PD-L1 and PIK3CA Testing Product Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global PD-L1 and PIK3CA Testing Product Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America PD-L1 and PIK3CA Testing Product Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America PD-L1 and PIK3CA Testing Product Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe PD-L1 and PIK3CA Testing Product Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe PD-L1 and PIK3CA Testing Product Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific PD-L1 and PIK3CA Testing Product Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific PD-L1 and PIK3CA Testing Product Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America PD-L1 and PIK3CA Testing Product Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America PD-L1 and PIK3CA Testing Product Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa PD-L1 and PIK3CA Testing Product Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa PD-L1 and PIK3CA Testing Product Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions PD-L1 and PIK3CA Testing Product Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions PD-L1 and PIK3CA Testing Product Sales Volume (%), (2019-2030)
    Figure 38. United States PD-L1 and PIK3CA Testing Product Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States PD-L1 and PIK3CA Testing Product Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe PD-L1 and PIK3CA Testing Product Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe PD-L1 and PIK3CA Testing Product Sales Value by Application (%), 2023 VS 2030
    Figure 44. China PD-L1 and PIK3CA Testing Product Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
    Figure 46. China PD-L1 and PIK3CA Testing Product Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan PD-L1 and PIK3CA Testing Product Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan PD-L1 and PIK3CA Testing Product Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea PD-L1 and PIK3CA Testing Product Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea PD-L1 and PIK3CA Testing Product Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia PD-L1 and PIK3CA Testing Product Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia PD-L1 and PIK3CA Testing Product Sales Value by Application (%), 2023 VS 2030
    Figure 56. India PD-L1 and PIK3CA Testing Product Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India PD-L1 and PIK3CA Testing Product Sales Value by Type (%), 2023 VS 2030
    Figure 58. India PD-L1 and PIK3CA Testing Product Sales Value by Application (%), 2023 VS 2030
    Figure 59. PD-L1 and PIK3CA Testing Product Industrial Chain
    Figure 60. PD-L1 and PIK3CA Testing Product Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35Z18485
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28M18423
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Compound Antibacterial Agent for Animal - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38V14855
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Antipyretic Stickers Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-22E8302
Thu Dec 12 00:00:00 UTC 2024

Add to Cart